Related Experiment Videos
Pelvic rhabdomyosarcoma in children.
B H Broecker1, N Plowman, J Pritchard
1Department of Urology, Hospital for Sick Children, London.
British Journal of Urology
|May 1, 1988
Summary
This study reviewed 20 children with pelvic rhabdomyosarcoma, finding a 55% survival rate. Combined treatments including chemotherapy, radiotherapy, and surgery offered the best cure rates for this pediatric cancer.
Area of Science:
- Pediatric Oncology
- Skeletal Muscle Tumors
Background:
- Pelvic rhabdomyosarcoma is a rare but aggressive childhood cancer.
- Treatment outcomes for this condition have historically varied.
Purpose of the Study:
- To review treatment outcomes for children with pelvic rhabdomyosarcoma.
- To identify effective therapeutic strategies for improving survival and bladder preservation.
Main Methods:
- Retrospective review of 20 pediatric patients diagnosed with pelvic rhabdomyosarcoma.
- Analysis of treatment modalities including surgery, radiotherapy, and systemic chemotherapy.
- Evaluation of survival rates and bladder salvage rates.
Main Results:
- Overall survival rate of 55% (11 out of 20 patients).
- Bladder salvage rate of 54.5% among survivors.
- Combination therapy (chemotherapy, radiotherapy, and/or surgery) demonstrated the highest efficacy in achieving cure.
Conclusions:
- Multimodal therapy is crucial for optimizing outcomes in pediatric pelvic rhabdomyosarcoma.
- Aggressive treatment regimens can lead to significant survival and functional preservation.
- Further research into refined treatment protocols may improve cure rates and reduce long-term sequelae.